Literature DB >> 17150058

Overutilization of central venous catheters in incident hemodialysis patients: reasons and potential resolution strategies.

Oliver Lenz1, Sanghamitra Sadhu, Alessia Fornoni, Arif Asif.   

Abstract

Even after adjusting for comorbidities, the outcomes in hemodialysis (HD) patients using a central venous catheter (CVC) as dialysis access are worse than in those with a permanent vascular access. In spite of this, nationwide data suggest that only about 25% of incident HD patients initiate dialysis with an arteriovenous fistula. We conducted a retrospective study to identify reasons and resolution strategies for CVC use in patients who initiated HD at an academic medical center with a well-established chronic kidney disease (CKD) clinic and a dedicated vascular surgeon. Estimated glomerular filtration rate (eGFR) loss over time to record progression of patients to HD was also examined. The charts of 170 consecutive patients were reviewed. Ninety-two percent were found to initiate HD using a CVC. Three factors explained 93% of all CVC in our cohort: absence of adequate predialysis care (45%), acute illness with failure to recover from an episode of acute renal failure (31%), and patient's failure to adhere to scheduled clinic or surgical appointments (17%). In addition, analyses of eGFR suggest that the velocity of GFR loss rather than a defined degree of renal function might be a better trigger for vascular access referral. We conclude that early referral, a close follow up of CKD patients who initiate dialysis due to acute illness, and patient education may have a positive impact to counteract overutilization of CVCs for dialysis. The rate in eGFR decline might also be used to calculate the referral time adequate for fistula creation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17150058     DOI: 10.1111/j.1525-139X.2006.00220.x

Source DB:  PubMed          Journal:  Semin Dial        ISSN: 0894-0959            Impact factor:   3.455


  7 in total

Review 1.  Type 2 translational research for CKD.

Authors:  Katherine R Tuttle; Delphine S Tuot; Cynthia L Corbett; Stephen M Setter; Neil R Powe
Journal:  Clin J Am Soc Nephrol       Date:  2013-04-25       Impact factor: 8.237

2.  Increased hemodialysis catheter use in Canada and associated mortality risk: data from the Canadian Organ Replacement Registry 2001-2004.

Authors:  Louise M Moist; Lilyanna Trpeski; Yingbo Na; Charmaine E Lok
Journal:  Clin J Am Soc Nephrol       Date:  2008-10-15       Impact factor: 8.237

Review 3.  Vascular access in elderly patients with end-stage renal disease.

Authors:  Nikolaos Bessias; Kosmas I Paraskevas; Effie Tziviskou; Vassilios Andrikopoulos
Journal:  Int Urol Nephrol       Date:  2008-09-16       Impact factor: 2.370

4.  Status of initiating pattern of hemodialysis: a multi-center study.

Authors:  Hye Eun Yoon; Sungjin Chung; Hyun Wha Chung; Mi Jung Shin; Sang Ju Lee; Young Soo Kim; Hyung Wook Kim; Ho Cheol Song; Chul Woo Yang; Dong Chan Jin; Yong Soo Kim; Suk Young Kim; Euy Jin Choi; Yoon Sik Chang; Young Ok Kim
Journal:  J Korean Med Sci       Date:  2009-01-28       Impact factor: 2.153

5.  Development of a decision aid to inform patients' and families' renal replacement therapy selection decisions.

Authors:  Jessica M Ameling; Priscilla Auguste; Patti L Ephraim; LaPricia Lewis-Boyer; Nicole DePasquale; Raquel C Greer; Deidra C Crews; Neil R Powe; Hamid Rabb; L Ebony Boulware
Journal:  BMC Med Inform Decis Mak       Date:  2012-12-01       Impact factor: 2.796

Review 6.  Shared decision-making in hemodialysis vascular access practice.

Authors:  Mariana Murea; Carl R Grey; Charmaine E Lok
Journal:  Kidney Int       Date:  2021-07-08       Impact factor: 18.998

7.  Patient-Related Barriers to Timely Dialysis Access Preparation: A Qualitative Study of the Perspectives of Patients, Family Members, and Health Care Providers.

Authors:  Konstadina Griva; Pei Shing Seow; Terina Ying-Ying Seow; Zhong Sheng Goh; Jason Chon Jun Choo; Marjorie Foo; Stanton Newman
Journal:  Kidney Med       Date:  2019-12-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.